← FDA Drug Approvals (Drugs@FDA)

VITRAKVI

NDA · New Drug Application · Sponsor: BAYER HEALTHCARE · Approved 2018-11-26

Drug application

FDA Application #

NDA211710

Application type

New Drug Application

Brand name

VITRAKVI

Generic name

LAROTRECTINIB

Active ingredients

LAROTRECTINIB SULFATE

Dosage form

SOLUTION

Route

ORAL

Marketing status

Prescription

Sponsor

BAYER HEALTHCARE

Manufacturer

Loxo Oncology, Inc.

First approval

2018-11-26

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown